Fig. 1From: Vasoresponsiveness in patients with heart failure (VASOR): protocol for a prospective observational studyRegulation of vascular smooth muscle tone. Binding of arginine vasopressin and norepinephrine to their receptor on the vascular smooth muscle cell surface results in an increase of the calcium concentration in the cytosol, thereby activating myosin light chain, leading to vasoconstriction. Vasodilators (e.g. nitric oxide, atrial natriuretic peptide) deactivate myosin light chain, introducing vasodilatation. AVP, arginine vasopressin; Ca2+, calcium ion, cGMP, cyclic guanosine monophosphate; MLCK, myosin light chain kinase; MLCP, myosin light chain phosphatase. Adapted from Landry and Oliver [10]Back to article page